Home Newsfeeds Entrada Therapeutics Inc Files For Mixed Shelf Of Up To $400M

Entrada Therapeutics Inc Files For Mixed Shelf Of Up To $400M

– SEC Filing

byBenzinga Newsdesk

November 1, 2022

1 minute read

– SEC Filing

Pinterest To Rally Over 25%? Here Are 5 Other Price Target Changes For Thursday

By Lisa Levin

October 6, 7:57 AM

Goldman Sachs raised Pinterest, Inc. (NYSE: PINS) price target from $24 to $31. Goldman Sachs analyst Eric Sheridan also upgraded the stock from Neutral to Buy. Pinterest shares fell 1.1% to close at $24.63 on Wednesday.

AMH

Gap CEO Sonia Syngal Steps Down; Company Anticipates Dim Q2 Outlook

By Shivani Kumaresan

July 12, 7:54 AM

Gap Inc (NYSE:GPS) said its president and CEO Sonia Syngal stepped down from her position and the company’s Board, effective immediately.…

GPS

Kinsale Capital Gr Q4 Adj. EPS $2.60 Beats $2.15 Estimate, Sales $242.96M Beat $234.51M Estimate

By Michael Horton

February 16, 5:12 PM

Kinsale Capital Gr (NYSE:KNSL) reported quarterly earnings of $2.60 per share which beat the analyst consensus estimate of $2.15 by 20.93 percent. This is a 47.73 percent increase over earnings of $1.76 per share from

KNSL

Fluor’s Financial Turnaround: Analyst Anticipates Cash Boosts And Revenue CAGR Of 9% Through 2025

By Nabaparna Bhattacharya

October 4, 4:22 PM

UBS analyst Steven Fisher upgraded Fluor Corporation (NYSE: FLR) to Buy from Neutral,

FLR

Entrada Therapeutics Inc Files For Mixed Shelf Of Up To $400M

Related Posts

Pinterest To Rally Over 25%? Here Are 5 Other Price Target Changes For Thursday

Gap CEO Sonia Syngal Steps Down; Company Anticipates Dim Q2 Outlook

Kinsale Capital Gr Q4 Adj. EPS $2.60 Beats $2.15 Estimate, Sales $242.96M Beat $234.51M Estimate

Fluor’s Financial Turnaround: Analyst Anticipates Cash Boosts And Revenue CAGR Of 9% Through 2025